道琼斯指数
52,475.1
涨跌
+97.53+0.19%
在 MEXC 探索美国生物科技板块股票,涵盖专注于药物研发、基因治疗及生物学研究的公司。比较股价、当日涨跌、市值和成交量,全面了解生物科技行业动态。

今日美股市场走势分化,道琼斯指数涨跌幅为 +0.19%,标普 500 指数为 +0.28%,纳斯达克综合指数为 +0.27%。个股方面,2,380 只上涨、2,737 只下跌,市场整体呈现分化格局。
| # | 股票 | 52 周价格区间 | |||||
|---|---|---|---|---|---|---|---|
| 51 | Ginkgo Bioworks Holdings, Inc.DNA | $13.35 | +16.68% | 3.51M | $739.26M | $5.37 - $18.22 | 0.00% |
| 52 | 4D Molecular Therapeutics, Inc.FDMT | $12.94 | +8.19% | 1.03M | $714.69M | $6.96 - $16.93 | 0.00% |
| 53 | Solid Biosciences Inc.SLDB | $6.47 | +4.68% | 1.37M | $694.28M | $3.79 - $11.45 | 0.00% |
| 54 | DBV Technologies S.A.DBVT | $10.66 | +5.93% | 185.78K | $670.34M | $8.63 - $26.18 | 0.00% |
| 55 | Aura Biosciences, Inc.AURA | $6.41 | +1.67% | 409.25K | $664.23M | $4.73 - $9.54 | 0.00% |
| 56 | Candel Therapeutics, Inc.CADL | $8.68 | +5.21% | 555.37K | $663.95M | $4.35 - $14.00 | 0.00% |
| 57 | Attovia Therapeutics, Inc.ATTO | $15.79 | +5.27% | 158.91K | $631.36M | $12.94 - $28.00 | 0.00% |
| 58 | Entera Bio Ltd.ENTX | $3.09 | +1.14% | 173.79K | $538.12M | $0.91 - $4.20 | 0.00% |
| 59 | NRC HealthNRC | $23.41 | +8.00% | 169.59K | $527.58M | $11.43 - $23.90 | 0.03% |
| 60 | REGENXBIO Inc.RGNX | $7.25 | +9.85% | 1.78M | $478.60M | $5.46 - $16.19 | 0.00% |
| 61 | Editas Medicine, Inc.EDIT | $2.94 | +13.46% | 4.11M | $452.29M | $1.66 - $3.94 | 0.00% |
| 62 | Allogene Therapeutics, Inc.ALLO | $1.30 | +6.10% | 9.84M | $450.87M | $1.04 - $4.46 | 0.00% |
| 63 | C4 Therapeutics, Inc.CCCC | $3.40 | +5.76% | 3.96M | $417.67M | $1.69 - $5.17 | 0.00% |
| 64 | Zura Bio LimitedZURA | $4.34 | +1.87% | 4.16M | $415.52M | $3.25 - $7.44 | 0.00% |
| 65 | Tectonic Therapeutic, Inc.TECX | $20.57 | +0.79% | 185.56K | $402.13M | $15.52 - $39.53 | 0.00% |
| 66 | Eikon Therapeutics, Inc.EIKN | $5.54 | -0.45% | 618.66K | $393.24M | $5.33 - $17.40 | 0.00% |
| 67 | Fennec Pharmaceuticals Inc.FENC | $10.85 | +2.17% | 114.96K | $381.22M | $5.65 - $13.25 | 0.00% |
| 68 | Kyverna Therapeutics, Inc.KYTX | $5.89 | +4.80% | 888.28K | $364.57M | $5.16 - $13.67 | 0.00% |
| 69 | IRulya Therapeutics Inc.IRLA | $32.62 | +0.91% | 61.97K | $353.59M | $25.13 - $41.00 | 0.00% |
| 70 | Surrozen, Inc.SRZN | $30.28 | +2.49% | 127.27K | $351.52M | $11.39 - $37.83 | 0.00% |
| 71 | X4 Pharmaceuticals, Inc.XFOR | $3.35 | +3.23% | 437.22K | $332.64M | $2.43 - $4.83 | 0.00% |
| 72 | Agenus Inc.AGEN | $7.13 | +7.29% | 632.48K | $322.23M | $2.71 - $10.31 | 0.00% |
| 73 | ProKidney Corp.PROK | $1.50 | -0.66% | 1.38M | $314.44M | $1.30 - $3.27 | 0.00% |
| 74 | SAB Biotherapeutics, Inc.SABS | $3.21 | +4.72% | 300.66K | $291.88M | $2.44 - $5.15 | 0.00% |
| 75 | Scribe Therapeutics Inc.SCTX | $17.57 | +10.43% | 297.97K | $291.64M | $13.50 - $39.60 | 0.00% |
| 76 | Century Therapeutics, Inc.IPSC | $1.50 | +3.45% | 750.81K | $270.71M | $0.43 - $3.04 | 0.00% |
| 77 | Ocugen, Inc.OCGN | $0.78 | +2.96% | 8.72M | $265.18M | $0.70 - $2.73 | 0.00% |
| 78 | Fate Therapeutics, Inc.FATE | $2.17 | +4.83% | 1.05M | $260.61M | $0.95 - $3.23 | 0.00% |
| 79 | Cabaletta Bio, Inc.CABA | $1.52 | +4.47% | 5.43M | $258.56M | $1.32 - $4.23 | 0.00% |
| 80 | Lexeo Therapeutics, Inc.LXEO | $3.14 | +9.41% | 1.00M | $257.54M | $2.55 - $10.99 | 0.00% |
| 81 | Alector, Inc.ALEC | $2.25 | +6.90% | 1.73M | $251.45M | $1.09 - $2.76 | 0.00% |
| 82 | Inhibikase Therapeutics, Inc.IKT | $1.61 | +2.87% | 314.79K | $225.35M | $1.33 - $2.61 | 0.00% |
| 83 | Artiva Biotherapeutics, Inc.ARTV | $4.28 | -1.68% | 2.79M | $209.10M | $2.96 - $14.53 | 0.00% |
| 84 | Palisade Bio, Inc.PALI | $1.19 | -0.83% | 14.87M | $208.08M | $1.11 - $2.85 | 0.00% |
| 85 | Precision BioSciences, Inc.DTIL | $7.50 | +10.01% | 171.39K | $207.01M | $3.53 - $9.62 | 0.00% |
| 86 | Alpha Cognition Inc.ACOG | $9.07 | +2.13% | 94.67K | $197.55M | $4.50 - $10.14 | 0.00% |
| 87 | Invivyd, Inc.IVVD | $0.62 | +4.79% | 2.67M | $181.57M | $0.53 - $3.07 | 0.00% |
| 88 | Coherus Oncology, Inc.CHRS | $1.16 | +8.41% | 1.21M | $179.38M | $0.94 - $2.62 | 0.00% |
| 89 | MaxCyte, Inc.MXCT | $1.70 | +10.06% | 1.63M | $174.93M | $0.64 - $1.80 | 0.00% |
| 90 | Acumen Pharmaceuticals, Inc.ABOS | $2.38 | +5.31% | 1.36M | $171.90M | $1.50 - $3.60 | 0.00% |
| 91 | Sutro Biopharma, Inc.STRO | $9.26 | +4.74% | 313.40K | $153.56M | $7.15 - $43.85 | 0.00% |
| 92 | Protara Therapeutics, Inc.TARA | $2.48 | +0.61% | 817.98K | $146.85M | $2.28 - $7.82 | 0.00% |
| 93 | Compass Therapeutics, Inc.CMPX | $0.77 | +2.96% | 1.40M | $138.67M | $0.73 - $6.88 | 0.00% |
| 94 | Outlook Therapeutics, Inc.OTLK | $0.54 | +1.89% | 1.95M | $132.19M | $0.16 - $2.54 | 0.00% |
| 95 | Humacyte, Inc.HUMA | $0.47 | +5.06% | 2.62M | $130.29M | $0.34 - $1.78 | 0.00% |
| 96 | Anavex Life SciencesAVXL | $1.30 | -0.76% | 912.07K | $120.23M | $1.14 - $8.45 | 0.00% |
| 97 | Voyager Therapeutics, Inc.VYGR | $1.84 | +6.94% | 935.77K | $113.69M | $1.71 - $5.48 | 0.00% |
| 98 | enGene Therapeutics Inc.ENGN | $1.57 | +1.29% | 985.49K | $105.48M | $1.40 - $12.25 | 0.00% |
| 99 | Black Diamond Therapeutics, Inc.BDTX | $1.82 | +4.29% | 980.79K | $104.85M | $1.60 - $4.94 | 0.00% |
| 100 | LENZ Therapeutics, Inc.LENZ | $3.19 | +1.11% | 478.74K | $100.07M | $3.06 - $32.13 | 0.00% |
| 现货美股(RealStocks) | 代币化美股(Tokenized Stocks) | 股票合约(Stock Futures) | |
|---|---|---|---|
| 是什么 | 美股上市公司的真实股份(现货美股) | 与美股/ETF 挂钩的区块链代币 | 以 USDT 保证金进行的股价合约交易 |
| 所有权 | 是 —— 真实持股 | 否 —— 仅为合成敞口 | 否 —— 仅为衍生品敞口 |
| 股东权益 | 有(如分红) | 无 | 无 |
| 交易时间 | 美股交易时段(盘前、正常、盘后、隔夜) | 24/7 全天候 | 支持交易对最高可达 24/7 全天候 |
| 持仓方式 | 买入并持有 | 买入并持有 | 支持多空双向、杠杆交易 |
| 适合人群 | 追求长期持有和分红收益的投资者 | 希望全天候获得股票敞口、无需持有股票的交易者 | 希望通过杠杆进行投机或对冲的短线/活跃交易者 |
通过 MEXC 合作的持牌券商购买真实美股,并可按适用条件享有股息等股东权益。
覆盖 7,000+ 只美国上市股票及 ETF,涵盖科技、金融、医疗、消费等多个行业。
支持 USDT 转入及 USDT/USD 转换,更便捷地为 RealStocks 账户提供资金。
以具有竞争力的交易成本参与真实美股交易,让更多资金用于投资策略。
本页面展示的美股价格、指数、排行榜、图表及其他市场数据可能来自第三方数据提供商,并可能存在延迟或误差。MEXC 提供的相关信息仅供参考和教育用途,不对其准确性或完整性作出保证。页面内容不构成任何金融或投资建议,也不构成买卖任何证券的推荐。美股交易存在风险,历史表现不代表未来结果,用户应在作出投资决定前进行独立研究。